These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26866895)

  • 1. Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solution.
    Prasad D; Chauhan H; Atef E
    Mol Pharm; 2016 Mar; 13(3):756-65. PubMed ID: 26866895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction.
    Chauhan H; Kuldipkumar A; Barder T; Medek A; Gu CH; Atef E
    Pharm Res; 2014 Feb; 31(2):500-15. PubMed ID: 24122167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
    Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
    Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions.
    Chauhan H; Hui-Gu C; Atef E
    J Pharm Sci; 2013 Jun; 102(6):1924-1935. PubMed ID: 23580406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
    Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of PVP molecular weight on the microwave assisted in situ amorphization of indomethacin.
    Doreth M; Löbmann K; Priemel P; Grohganz H; Taylor R; Holm R; Lopez de Diego H; Rades T
    Eur J Pharm Biopharm; 2018 Jan; 122():62-69. PubMed ID: 28986296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.
    Chokshi RJ; Sandhu HK; Iyer RM; Shah NH; Malick AW; Zia H
    J Pharm Sci; 2005 Nov; 94(11):2463-74. PubMed ID: 16200544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase Behavior of Resveratrol Solid Dispersions Upon Addition to Aqueous media.
    Wegiel LA; Mosquera-Giraldo LI; Mauer LJ; Edgar KJ; Taylor LS
    Pharm Res; 2015 Oct; 32(10):3324-37. PubMed ID: 25975588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.
    Li Y; Rantanen J; Yang M; Bohr A
    Eur J Pharm Sci; 2019 Mar; 129():1-9. PubMed ID: 30553059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.
    Goddeeris C; Willems T; Houthoofd K; Martens JA; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Nov; 70(3):861-8. PubMed ID: 18691650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacts of Polymeric Additives on Nucleation and Crystal Growth of Indomethacin from Supersaturated Solutions.
    Cheng H; Mao L; Zhang S; Lv H
    AAPS PharmSciTech; 2019 May; 20(5):193. PubMed ID: 31115746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method to predict the equilibrium solubility of drugs in solid polymers near room temperature using thermal analysis.
    Bellantone RA; Patel P; Sandhu H; Choi DS; Singhal D; Chokshi H; Malick AW; Shah N
    J Pharm Sci; 2012 Dec; 101(12):4549-58. PubMed ID: 22987330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc.
    Sun Y; Tao J; Zhang GG; Yu L
    J Pharm Sci; 2010 Sep; 99(9):4023-31. PubMed ID: 20607809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
    Sun DD; Lee PI
    J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of molecular-interaction sites between lowly hydrolyzed polyvinyl alcohols and indomethacin by NMR spectroscopy.
    Mori Y; Takahashi M; Ohno Y; Okura R; Ishida M; Higashi T; Motoyama K; Arima H
    Int J Pharm; 2018 Oct; 549(1-2):456-465. PubMed ID: 30110620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.